002773 康弘药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.67414.20913.8047.110-5.200
总资产报酬率 ROA (%)4.30212.85812.2196.034-4.207
投入资产回报率 ROIC (%)4.64714.05713.5166.877-4.430

边际利润分析
销售毛利率 (%)89.49088.92288.55090.16489.994
营业利润率 (%)40.86231.86629.9609.851-15.545
息税前利润/营业总收入 (%)39.32029.85729.0759.960-16.583
净利润/营业总收入 (%)33.99326.05525.54711.679-8.189

收益指标分析
经营活动净收益/利润总额(%)97.30793.23188.628111.772119.577
价值变动净收益/利润总额(%)0.0483.5823.6946.717-6.562
营业外收支净额/利润总额(%)-0.125-2.2001.4499.7211.391

偿债能力分析
流动比率 (X)9.5828.1076.0975.5424.044
速动比率 (X)8.9067.4905.6205.0993.799
资产负债率 (%)7.3588.41510.54112.23517.788
带息债务/全部投入资本 (%)-0.139-0.149-0.179-0.232--
股东权益/带息债务 (%)-71,350.165-66,839.353-55,068.346-41,848.930-17,254.009
股东权益/负债合计 (%)1,258.1251,087.270848.043715.530462.187
利息保障倍数 (X)-26.363-22.569-21.924-10.46020.254

营运能力分析
应收账款周转天数 (天)13.61314.10117.67625.6420.000
存货周转天数 (天)315.458301.598290.659271.7030.000